PUBLIC ISSUE OF [●] EQUITY SHARES OF FACE VALUE ` 10 EACH (THE “EQUITY SHARES”) OF EMCURE PHARMACEUTICALS LIMITED (THE
“COMPANY” OR THE “ISSUER”) FOR CASH AT A PRICE OF ` [●] PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF ` [●] PER EQUITY SHARE)
AGGREGATING TO ` [●] MILLION CONSISTING OF A FRESH ISSUE OF [●] EQUITY SHARES AGGREGATING UP TO ` 3,000 MILLION (THE “FRESH
ISSUE”) AND AN OFFER FOR SALE OF UP TO 2,513,057 EQUITY SHARES BY THE SELLING SHAREHOLDERS (AS DEFINED IN THE SECTION
“DEFINITIONS AND ABBREVIATIONS”) AGGREGATING UP TO ` [●] MILLION (THE “OFFER FOR SALE” AND TOGETHER WITH THE FRESH ISSUE,
THE “ISSUE”). THE ISSUE WILL CONSTITUTE [●]% OF THE POST-ISSUE PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY.
THE FACE VALUE OF EQUITY SHARES IS ` 10 EACH. THE PRICE BAND AND THE MINIMUM BID LOT WILL BE DECIDED BY OUR COMPANY
https://www.sebi.gov.in/sebi_data/attachdocs/1372676629625.pdf